September 2026

Join WhatsApp Channel 

GPAT caoching
Work as Senior Associate Quality Complaints at Amgen
18 September 2026

Work as Senior Associate Quality Complaints at Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Amgen helped establish the biotechnology industry more than 40 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.  

Post : Sr Associate Quality Complaints

Pharma Apprenticeship Training at Sun Pharma
18 September 2026
Pharma Apprenticeship Training at Sun Pharma

Sun Pharma is India’s No. 1 pharmaceutical company and a leading global player in specialty medicines. With over 40 manufacturing facilities and a diverse portfolio, we deliver high-quality medicines across 100 countries. Driven by a commitment to innovation, we continuously strive to enhance access to medicines and improve patient care, creating better health outcomes for millions around the world.

Walk in Drive for APPRENTICESHIP TRAINING

Symbiotec Pharmalab Invites Pharma and Science candidates in Production, QC and QA Department
18 September 2026
Symbiotec Pharmalab Invites Pharma and Science candidates in Production, QC and QA Department
Symbiotec Pharmalab Limited is a research-driven pharmaceutical and biotechnology company headquartered in Indore, Madhya Pradesh, India. It is a global leader in the manufacturing of corticosteroid and steroidal hormone Active Pharmaceutical Ingredients (APIs).
H&H Healthcare and Cosmetics Hiring Regulatory Affairs Assistant Manager / Deputy Manager
18 September 2026
H&H Healthcare and Cosmetics Hiring Regulatory Affairs Assistant Manager / Deputy Manager
Ensure compliance with FSSAI regulations, guidelines, licensing requirements, and applicable standards.  Manage product registrations, approvals, licenses, renewals, amendments, and regulatory submissions. 
Apply Online for Risk Evidence Writer at Reckitt
18 September 2026
Apply Online for Risk Evidence Writer at Reckitt
Risk Evidence Writer inputs into of all aspects of the Reckitt global signal management process, including signal surveillance for medicines, medical devices, cosmetics and other Reckitt products.
Require Plant HR – Talent Acquisition at Aculife
18 September 2026
Require Plant HR – Talent Acquisition at Aculife
ACULIFE HEALTHCARE PRIVATE LIMITED, Aculife has been associated with the healthcare segment since over last 30 years now, which is the prime reason why the name spells unparalleled growth and absolute reliability.
Takeda and Dr. Reddy’s Partner to Promote and Distribute QDENGA® in India’s Private Pediatric and Adult Market
18 September 2026
Takeda and Dr. Reddy’s Partner to Promote and Distribute QDENGA® in India’s Private Pediatric and Adult Market
QDENGA®, across India’s private market for pediatric and adult vaccination in India. Subject to completion of applicable processes with local authorities, the vaccine is anticipated to become available in the first half of 2027.
FDA Expands Finerenone Approval to Type 1 Diabetes-Linked Kidney Disease
18 September 2026
FDA Expands Finerenone Approval to Type 1 Diabetes-Linked Kidney Disease
The U.S. Food and Drug Administration (FDA) has approved Kerendia (finerenone) for a new indication in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D). Bayer announced it as the first FDA-approved treatment option in more than 30 years for adults with CKD associated with type 1 diabetes
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
18 September 2026
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
Sanfilippo syndrome type A is a rare inherited disorder that primarily affects the brain and nervous system. Children with the condition can experience progressive loss of cognitive, language and other developmental abilities. Before this approval, there was no FDA-approved treatment specifically designed to address the underlying cause of MPS IIIA
Operation TrialBlazer: The US Plan to Bring Clinical Trials Back Home
18 September 2026
Operation TrialBlazer: The US Plan to Bring Clinical Trials Back Home

Operation TrialBlazer is a coordinated, department-wide initiative launched by the US Department of Health and Human Services (HHS) on June 22, 2026, aimed at restoring America's leadership in clinical research.